K. E. Truitt

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis

Thomas J. Schnitzer, K. E. Truitt, Roy Fleischmann et al. · Clinical Therapeutics · 1999 · 137 citations

Drug Safety, Rheumatology, Rheumatoid Disorder +9

A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis

K. E. Truitt, Rhoda Sperling, W. H. Ettinger et al. · Aging Clinical and Experimental Research · 2001 · 79 citations

Advanced Elderly Patients, Chronic Musculoskeletal Condition, Clinical Trials +4

A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis

Piet P. Geusens, K. E. Truitt, P.P. Sfikakis et al. · Scandinavian Journal of Rheumatology · 2002 · 46 citations

Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes

Allison B. Goldfine, Vivian Fonseca, Michelle R. Jones et al. · Hormone and Metabolic Research · 2009 · 41 citations

Drug Safety, Metabolic Syndrome, Adverse Events +13

Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor to insulin receptor substrate 1.

Víctor Sánchez‐Margalet, I D Goldfine, K. E. Truitt et al. · Molecular Endocrinology · 1995 · 33 citations · Full text

Insulin Receptor, Insulin Signaling, Molecular Pharmacology +19